| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-05 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-05 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-05 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |